riliprubart placebo, solution for injection in prefilled pen (PFP), riliprubart placebo, solution for injection in vial, riliprubart, riliprubart
EFC17236
Phase 3 small_molecule active
Quick answer
riliprubart placebo, solution for injection in prefilled pen (PFP), riliprubart placebo, solution for injection in vial, riliprubart, riliprubart for Polyneuropathy, Inflammatory Demyelinating, Chronic is a Phase 3 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Polyneuropathy, Inflammatory Demyelinating, Chronic
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active